B&F Diagnostics, a hybrid advanced molecular biology techniques linked to water waste technology will enable wastewater treatment plants to decrease energy costs, eliminate solid-separation problems, and avoid regulatory fines. This innovative approach provides higher performance and accuracy than those available through existing identification methodologies. Reverse Blot Dot Hybridization, (REBA)'s modest equipment costs and platform, can be easily used by operating staff in wastewater plants, and allows these industries to obtain real time results, crucial in protecting public health and reducing operational costs.
Our company will sustain its competitive advantage by leveraging needs to solve solid separation problems with the implementation of ever increasing regulations on wastewater. The ability to customize our product to the needs of client utilities and a pipeline of related innovative products will allow the company to expand its market share.
The current format, developed by our company, will be sold as a diagnostic kit including the identification membrane, reagents and optional off-the-shelf molecular diagnostic device.